|
A.Yu.Kochish, MD, S.N. Ivanov
COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF DOMESTIC GENERICS AND ORIGINAL DRUG OF ZOLEDRONIC ACID IN PATIENTS WITH LOW-ENERGY VERTEBRAL FRACTURES AND POSTMENOPAUSAL OSTEOPOROSIS
|
№s5-14 / 2014
|
|
E.V. Biryukova
POTENTIALS FOR THE USE OF ZOLENDRONATE IN THE TREATMENT OF OSTEOPOROSIS
|
№s5-14 / 2014
|
|
N.N. Semenov
BONDRONAT – THE EXPERIENCE OF USE IN PATIENTS WITH BONE METASTASIS FROM BREAST CANCER
|
№8 / 2014
|
|
I.A. Kurnikova
FOROSA IN THE THERAPY OF CALCIUM AND PHOSPHORUS METABOLISM DISORDERS IN ENDOCRINOLOGICAL PATIENTS
|
№5 / 2014
|
|
N.A. Shostak, A.A. Kondrashov, A.A. Muradyants, V.S. Shemenkova
OSTEOPOROSIS IN MEN: APPROACHES TO THERAPY FROM THE PERSPECTIVE OF CURRENT POSITION
|
№s5-13 / 2013
|
|
E.V. Biryukova
DO WE KNOW EVERYTHING ABOUT TREATMENT OF STEROID-INDUCED OSTEOPOROSIS?
|
№s5-13 / 2013
|
|
I.A. Baranova
OSTEOPOROSIS IN PRACTICE OF PULMONOLOGIST
|
№s5-13 / 2013
|
|
N.N. Semenov
THE USE OF BISPHOSPHONATES FOR THE PREVENTION OF BONE METASTASES IN BREAST CANCER PATIENTS
|
№8 / 2013
|
|
O.B. Ershova, A.V. Nazarova
BISPHOSPHONATES - DURATION OF USE IN OSTEOPOROSIS, REASONABILITY AND SAFETY
|
№7 / 2013
|
|
S.G. Anikin, N.V. Toroptsova
Bisphosphonates: What We Know About Adverse Events Associated With Their Use
|
№19 / 2012
|
|
I.I .Zubkov, Yu.A. Safonova, E.G. Zotkin
Risedronate In The Treatment Of Osteoporosis: Efficacy And Tolerability
|
№16 / 2012
|
|
O. M. Lesnyak
Modern Approaches To The Diagnosis And Treatment Of Osteoporosis
|
№s1-12 / 2012
|
Русский
